Australian scientists genetically engineer common fly species to eat more of humanity’s waste | Black soldier flies could help cut planet-warming methane produced when organic waste breaks down.

Read Full Article

#sustainablefuture #biotech #environmentalscience #wastemanagement #climateaction

🧠 Researchers have identified a nanoscale molecular scaffold that protects sensory axons from damage, a breakthrough that could lead to new therapies for neuronal injury and neurodegenerative diseases.

🌟 This scaffold, made of spectrins, acts like a "skin cast" around the axon, offering external support that complements internal protection mechanisms, a discovery made in roundworms, humans, and other species.

💡 The findings, published in Science Advances, suggest that targeting the spectrin scaffold in the tissue surrounding axons could offer novel ways to prevent and treat nerve damage.

#Neuroscience #Biotech #MedicalResearch

Scientists 🔬 combine caffeine ☕ with CRISPR 🧬, the gene-editing tool, using engineered nanobodies 🧪 that can be switched on by caffeine ☕, in animals models 🐁. In the long term, it may be possible to engineer cells 🧫 that allow people with diabetes 🩸 to boost insulin production simply by drinking a cup of coffee ☕.

Read Full Article

#CRISPR #Caffeine #Nanobodies #Biotech #DiabetesResearch

✨ Northwestern University scientists have successfully grown human spinal cord organoids in lab dishes, mimicking spinal cord injuries.

✨ A novel therapy, using "dancing" molecules called IKVAV-PA, was applied to these injured organoids, significantly reducing scar tissue and promoting nerve cell regeneration. This treatment mirrors promising results seen previously in mice.

✨ This breakthrough represents a crucial step toward developing new treatments for paralysis caused by spinal cord injuries, moving beyond animal models to test therapies directly on human tissue.

#SpinalCordInjury #RegenerativeMedicine #Biotech

🧬 Evo 2, an open-source AI, has been trained on genomes from bacteria, archaea, and eukaryotes, processing trillions of DNA base pairs.

🧠 This advanced AI can now identify key features in complex genomes, such as regulatory DNA and splice sites, which are difficult for humans to locate.

#AI #Genomics #BioTech

Implantable 'living pharmacy': tiny device, implantable and engineered with cells, produces a combination of different medicines, can function continuously inside the body for several weeks, potentially aiding in the treatment of chronic diseases

Read Full Article

#BioTech #LivingMedicine #ImplantableTherapeutics

🧬 "Living Pharmacies" Breakthrough: Scientists co-led by Northwestern University have developed HOBIT, a tiny implantable device that houses engineered cells to continuously produce three different medicines (an anti-HIV antibody, a type 2 diabetes drug, and an appetite-regulating hormone) inside the body.

💡 Oxygen for Cell Survival: HOBIT's key innovation is an integrated oxygen generator that provides a steady supply to engineered cells, dramatically improving their survival rates (65% viable in HOBIT vs. 20% in controls) and enabling sustained drug delivery for several weeks in small animal models.

🧪 Potential for Chronic Conditions: This "living pharmacy" technology, published in Device, holds promise for treating chronic diseases with a single, long-lasting therapy, potentially eliminating the need for frequent injections or pills.

#BioTech #MedicalDevices #HealthTech

🌱 Scientists have engineered tobacco plants to produce five potent psychedelic compounds: psilocin, psilocybin, DMT, bufotenin, and 5-methoxy-DMT.

🔬 The process uses agroinfiltration, a temporary gene-editing technique, allowing plants to create these compounds without altering their permanent DNA.

🌿 This method offers a simpler and more sustainable way to produce these substances for research and potential therapeutic uses compared to traditional methods.

#Psychedelics #Biotech #PharmaFarming

FDA to weigh easing limits on unproven peptides favored by RFK Jr. | AP News

Read Full Article

#FDA #Peptides #Biotech

🔬 MIT engineers have developed injectable "mini livers" to assist patients with chronic liver disease, aiming to restore essential liver functions without full transplant surgery.

💧 In a study with mice, these injected liver cells remained viable for at least two months, producing key enzymes and proteins typically made by the liver.

💉 The technology uses hydrogel microspheres to keep cells localized and connected to blood vessels, allowing them to function as a stable tissue graft. Ultrasound guidance is used for injection and monitoring.

🌟 This approach could serve as an alternative to transplantation or a bridge therapy, providing support until a donor organ is available.

#BioTech #MedicalInnovation #LiverDisease

💧 NUS scientists have developed a revolutionary treatment for dry eye disease using a plant-derived extract that enables eye cells to produce a key protective molecule when exposed to light.

🌱 This light-activated technology, derived from spinach, aims to keep eyes continuously hydrated and has shown promise in preclinical studies, reversing corneal damage within five days.

🔬 Published in the journal Cell on 15 May 2026, the innovation involves transplanting photosynthetic machinery into corneal cells to generate NADPH, which combats damaging molecules and reduces inflammation.

#DryEye #MedicalBreakthrough #BioTech

🔬 Researchers have developed a new "transcriptomic clock" that measures biological age by analyzing gene activity, offering a more precise understanding of aging than chronological age.

🧬 This tool examines RNA to see which genes are active as we age, analyzing over 11,000 samples from mice, rats, macaques, and humans across various tissues.

🌍 Findings reveal remarkably similar gene expression patterns across species and organs, suggesting a shared biological aging framework. Genes linked to cell repair indicate slower aging, while those tied to inflammation and cell death suggest faster aging.

📈 Beyond predicting mortality risk, this technology could help evaluate the impact of diseases, medicines, and lifestyle on biological aging, providing rapid insights without years of observation.

#AgingResearch #BioTech #Science

💧 Researchers have developed a low-cost sensor that detects dopamine in artificial tears, potentially aiding in the early detection of neurological disorders like Parkinson's disease.

🔬 The postage-stamp-sized sensor uses laser-converted graphene to produce an electrical signal when reacting with dopamine, accurately measuring concentrations from below healthy baseline to three times higher.

👁️ This non-invasive tear-based monitoring technology aims to enable clinical interventions before major symptoms manifest, offering a faster and less invasive alternative to current methods.

#Neuroscience #Biotech #HealthTech

🔬 Miniature human organs, known as organoids, will be grown from NHS patient cells in Cambridge to improve medicine testing and reduce animal use in drug development. This initiative, funded with £20m from the Medical Research Council, aims for more accurate tests based directly on human tissues.

🔬 Scientists will use these organoids to understand how diseases vary between patients, enabling personalized treatment identification. This approach marks a significant shift from traditional animal models, which often show differing results compared to human trials.

🔬 The research hub in Cambridge will create a library of standardized organoids for academics and the pharmaceutical industry. This is part of a plan by Keir Starmer's government to accelerate the reduction of animals in research using "new approach methodologies" like organoids and AI.

🔬 Last year, 2.54 million animal testing procedures were conducted in Britain, a 3.8% decrease from 2024. While the majority involved mice, rats, fish, and birds, 1% used protected species.

#BioTech #MedicalResearch #PersonalizedMedicine

🔬 Breakthrough Gene Therapy Restores Vision in Dogs: Researchers have successfully used a single-dose gene therapy to halt and even reverse vision loss caused by a faulty CaBP4 gene in whippet dogs. This therapy not only improved vision, especially in dim light, but also physically repaired damaged retinal connections.

🔬 Potential for Nerve Cell Repair in Mammals: The study, published in Molecular Therapy Advances, demonstrates the ability to repair nerve cells in adult mammals, a feat previously thought impossible. This research opens doors for new treatments for a wider range of conditions involving damaged neural networks.

🔬 Restored Retinal Structure and Function: The gene therapy provided a working copy of the CaBP4 gene, correcting "typos" in the genetic blueprint. This led to expanded crucial retinal layers and matured synaptic ribbons within the eye's light-sensing cells, restoring a near-normal anatomical arrangement.

#GeneTherapy #VisionRestoration #Biotech